Skip to main content
Equibles

1492 Capital Management LLC

Position in KURA — Kura Oncology, Inc.

CIK 1584087 MILWAUKEE, WI
Back to KURA Full portfolio

Position in KURA

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$5,124,668
+$1,172,489 QoQ
Shares Held
467,153
-3.9% QoQ
Ownership
0.525%
of shares outstanding
% of Portfolio
1.57%
of 13F equity value
Holder Rank
#34
of 221 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KURA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

1492 Capital Management LLC holds $24,471,164 across 11 Biotechnology names. KURA ranks #2 (20.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AXSM
Axsome Therapeutics, Inc.
 29,307 $7,173,474
2 KURA
Kura Oncology, Inc.
This page 		467,153 $5,124,668
3 ARQT
Arcutis Biotherapeutics, Inc.
 116,211 $3,047,052
4 VKTX
Viking Therapeutics, Inc.
 55,723 $2,173,754
5 MNKD
Mannkind Corp
 481,722 $2,052,135
6 DNLI
Denali Therapeutics Inc.
 66,368 $1,706,984
7 SNDX
Syndax Pharmaceuticals Inc
 66,997 $1,464,554
8 FENC
Fennec Pharmaceuticals Inc.
 65,149 $700,351

All Filings in KURA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,124,668 467,153
2026-03-31 $3,952,179 486,123
2025-12-31 $4,702,908 452,638
2025-09-30 $3,943,914 445,640
2025-06-30 $2,446,174 423,947
2025-03-31 $2,836,323 429,746
2024-12-31 $2,984,028 342,598
2024-09-30 $1,430,796 73,224
2024-06-30 $1,497,675 72,738
2024-03-31 $1,554,061 72,858
2023-12-31 $1,459,570 101,500
2023-09-30 $916,249 100,466
2023-06-30 $1,062,930 100,466
2023-03-31 $1,229,273 100,513
2022-12-31 $1,247,775 100,546
2022-09-30 $548,640 40,164
2022-06-30 $736,371 40,173